利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

9 条记录 (耗时 0.035 秒)

    Histone deacetylase inhibitors
    2.
    发明授权
    Histone deacetylase inhibitors 失效
    组蛋白脱乙酰酶抑制剂

    公开(公告)号：US07399884B2

    公开(公告)日：2008-07-15

    申请号：US11557402

    申请日：2006-11-07

    申请人： Jerome C. Bressi ,  Sheldon X. Cao ,  Jeffrey A. Stafford ,  Phong H. Vu

    发明人： Jerome C. Bressi ,  Sheldon X. Cao ,  Jeffrey A. Stafford ,  Phong H. Vu

    IPC分类号： C07C259/04 ,  C07C229/34 ,  C07D231/16 ,  C07D239/22 ,  C07D241/36

    CPC分类号： C07C259/06 ,  C07D231/16 ,  C07D239/38 ,  C07D241/44

    摘要： Histone deacetylase inhibitors and uses thereof are provided that have the general formula wherein R1, R2, R3 and R4 are each independently selected from the group consisting of hydrogen, a substituted or unsubstituted straight chained C1-12 alkyl, C2-12 aminoalkyl or C2-12 oxaalkyl, and a substituted and unsubstituted 3, 4, 5, 6, 7 or 8 membered ring, with the proviso that R3 and R4 are not both hydrogen;R5 is selected from the group consisting of a carbonyl, a substituted or unsubstituted C1-3 alkyl, a substituted or unsubstituted —C1-3 alkyl-C(O), a substituted or unsubstituted —C(O)—C1-3 alkyl, and a substituted or unsubstituted —C(O)C(O)C1-3 alkyl;M is a substituent capable of complexing with a protein metal ion; andL is a substituent comprising a chain of 3-12 atoms connecting the M substituent to the carbon atom alpha to the L substituent.

    摘要翻译： 提供组蛋白脱乙酰酶抑制剂及其用途，其具有以下通式：其中R 1，R 2，R 3和R 4， / SUB>各自独立地选自氢，取代或未取代的直链C 1-12烷基，C 2-12-12氨基烷基或C 1 -C 12烷基， 2-12个氧杂烷基，以及取代和未取代的3,4,5,6,7或8元环，条件是R 3和R 4 不是氢; R 5选自羰基，取代或未取代的C 1-3烷基，取代或未取代的C 1-3烷基， 烷基-C（O），取代或未取代的-C（O）-C 1-3烷基和取代或未取代的-C（O）C（O）C 1-3烷基; M是能与蛋白质金属离子络合的取代基; L是包含连接M取代基与L取代基的α原子的3-12个原子的链的取代基。

    Histone deacetylase inhibitors
    6.
    发明授权
    Histone deacetylase inhibitors 失效
    组蛋白脱乙酰酶抑制剂

    公开(公告)号：US07154002B1

    公开(公告)日：2006-12-26

    申请号：US10681049

    申请日：2003-10-07

    申请人： Jerome C. Bressi ,  Sheldon X. Cao ,  Jeffrey A. Stafford ,  Phong H. Vu

    发明人： Jerome C. Bressi ,  Sheldon X. Cao ,  Jeffrey A. Stafford ,  Phong H. Vu

    IPC分类号： C07C259/04 ,  C07C229/34 ,  C07D231/16 ,  C07D239/22 ,  C07D241/36

    CPC分类号： C07C259/06 ,  C07D231/16 ,  C07D239/38 ,  C07D241/44

    摘要： Histone deacetylase inhibitors and uses thereof are provided that have the general formula wherein R1, R2, R3 and R4 are each independently selected from the group consisting of hydrogen, a substituted or unsubstituted straight chained C1-12 alkyl, C2-12 aminoalkyl or C2-12 oxaalkyl, and a substituted and unsubstituted 3, 4, 5, 6, 7 or 8 membered ring, with the proviso that R3 and R4 are not both hydrogen; R5 is selected from the group consisting of a carbonyl, a substituted or unsubstituted C1-3 alkyl, a substituted or unsubstituted —C1-3 alkyl-C(O), a substituted or unsubstituted —C(O)—C1-3 alkyl, and a substituted or unsubstituted —C(O)C(O)C1-3 alkyl; M is a substituent capable of complexing with a protein metal ion; and L is a substituent comprising a chain of 3–12 atoms connecting the M substituent to the carbon atom alpha to the L substituent.

    摘要翻译： 提供组蛋白脱乙酰酶抑制剂及其用途，其具有以下通式：其中R 1，R 2，R 3和R 4， / SUB>各自独立地选自氢，取代或未取代的直链C 1-12烷基，C 2-12-12氨基烷基或C 1 -C 12烷基， 2-12个氧杂烷基，以及取代和未取代的3,4,5,6,7或8元环，条件是R 3和R 4 不是氢; R 5选自羰基，取代或未取代的C 1-3烷基，取代或未取代的C 1-3烷基， 烷基-C（O），取代或未取代的-C（O）-C 1-3烷基和取代或未取代的-C（O）C（O）C 1-3烷基; M是能与蛋白质金属离子络合的取代基; L是包含连接M取代基与L取代基的α原子的3-12个原子的链的取代基。